SIGILON THERAPEUTICS INC (SGTX)

US82657L2060 - Common Stock

22.47  -0.59 (-2.56%)

After market: 23 +0.53 (+2.36%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
14.64M12.94M9.60M13.37M14.16M
Operating Expenses
52.07M56.61M85.23M66.02M58.28M
Research and Development
33.80M37.63M65.07M53.49M48.11M
Selling, General, and Administrative Expenses
18.28M18.98M20.17M12.53M10.17M
Operating Income
-37.44M-43.67M-75.64M-52.64M-44.12M
Interest Income/Expense
-1.05M-1.34M-1.73M-890.00K410.00K
Other Income/Expense
1.41M1.45M55.00K-733.00K-210.00K
Non Recurring Items
N/AN/A0.00-343.00K0.00
Income Before Taxes
-37.08M-43.56M-77.31M-54.61M-43.93M
Net Income
-37.08M-43.56M-77.31M-54.61M-43.93M
EBITDA
-36.17M-42.40M-74.52M-51.79M-43.44M
 
Per Share Data
EPS Diluted Total Ops
-9.55-17.48-31.55-22.56-1.53
Non GAAP EPS
-9.67-7.11-2.43N/AN/A
 
Statistics
Profit Margin
-253.33%-336.53%-805.41%-408.31%-310.24%
Operating Profit Margin
-255.76%-337.35%-787.96%-393.61%-311.58%

All data in USD

Charts